Adherium and Vitalus Health Launch Commercial Program to Support Patients with Asthma and COPD

/in

Link to Full Article San Mateo, CA – August 23, 2018: Adherium (ASX:ADR) a digital health platform focused on improving medication adherence and patient outcomes, and Vitalus Health, a leading provider of comprehensive health and wellness solutions that focus on pulmonary disease management, today announced a broadened strategic program encompassing Adherium’s Hailie™ solution. With the expansion of […]

Read more

Adherium announces $1.8m secured notes financing; ASX waiver granted

/in

Melbourne, Australia – August 22, 2019: Adherium Limited (“Adherium” or the “Company”) (ASX: ADR) is pleased to announce it has received commitments from existing significant shareholders and new investors to subscribe for $1.8m of secured notes to be issued the Company (2019 Notes). Subscribers to the 2019 Notes include One Funds Management Limited as […]

Read more

Adaptix secures STFC Bridging for Innovators grant…

/in

Link to Full Article Adaptix have just won an STFC Bridging for Innovators (B4i) grant worth over £40,000 for work with the prestigious Ultra High Vacuum Group at STFC Daresbury – to develop cleaning processes for the manufacture of Adaptix’s patented Flat Panel X-ray Source. Bridging for Innovators (B4I) is an Industrial Strategy Challenge Fund (ISCF) programme run […]

Read more

Adherium and Summatix announce strategic initiative to enhance Hailie™ Solution’s Digital Platform Impact

/in

Melbourne, Australia – August 20, 2019: Leading respiratory medical device company Adherium (ASX:ADR) has unveiled its new strategic data-based initiative with Summatix Pty Ltd, with the objective of enabling clinicians globally to enhance their care of patients with asthma and chronic obstructive pulmonary disease (COPD). This follows Adherium’s post-reorganisation business model of enhancing its sensor […]

Read more

Armata Pharmaceuticals Announces Second Quarter Results and Provides Corporate and Clinical Update

/in

Link to Full Article MARINA DEL REY, Calif., Aug. 14, 2019 /PRNewswire/ — Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (“Armata” or the “Company”), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced second quarter results and provided a corporate and clinical update. Key Second Quarter and Subsequent Period Highlights: Successfully completed […]

Read more

Micro-encapsulation matters and this $5.5 million infant formula deal proves it

/in

Link to full Article Micro-encapsulation may sound like something that only matters for the highly scientifically-literate. But in a competitive market like infant formula it could make a big difference. Stockhead spoke with both sides of a deal completed last week over this trend. It involves venture capitalists BioScience Managers, which invested $5.5 million in […]

Read more

BioScience Managers invests in CSIRO-derived microencapsulation technology

/in

Melbourne, Australia and London, UK 8 August 2019 – BioScience Managers (BSM), one of Australia’s leading international healthcare investment firms, today announces an investment in Sydney-based nutrition technology company, Pharmamark Nutrition Pty. Ltd. BSM has invested A$5.5 million in Pharmamark Nutrition. The funds will go toward the development of CSIRO’s microencapsulation technology for Pharmamark’s IntEncap™ product […]

Read more

Leading investment firm invests in new CSIRO health technology

/in

Link to Full Article BioScience Managers (BSM) is one of Australia’s leading international healthcare investment firms. The CSIRO is Australia’s most loved, respected and revered science and research organisation, responsible for fast Wi-Fi, Aerogard and polymer banknotes among many other notable discoveries. Currently it is working on the first gravitational waves in space, growing gluten-free […]

Read more